| RGLS Market Cap History Table | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Also see: RGLS Shares Outstanding History and RGLS YTD Return |
| RGLS Market Cap History Chart | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
-1.71% CAGR 
Mouse over chart for data details
| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| RGLS Stock Price Chart |
| About Regulus Therapeutics Inc |
| Regulus Therapeutics is a biopharmaceutical company focused on discovering and developing drugs that target microRNAs to treat diseases. Co.'s key product candidates are RG-012 and RGLS4326. RG-012 is an anti-miR targeting miR-21 for the treatment of Alport syndrome, a life-threatening kidney disease. RGLS4326 is an anti-miR targeting miR-17 for the treatment of autosomal dominant polycystic kidney disease. Co. has multiple programs in various stages of preclinical development including RGLS5579 as a clinical candidate in its glioblastoma multiforme program, its preclinical programs targeting the Hepatitis B virus and Non-Alcoholic Steatohepatitis program. We show 46 historical shares outstanding datapoints in our RGLS shares outstanding history coverage, used to compute RGLS market cap on those dates. Understanding the changing numbers of shares outstanding, the changing share price, and the resulting changing RGLS market cap history over the course of time is important for investors interested in comparing RGLS's market cap history versus its peers. Many "beginner" or "novice" investors will look at one stock trading at a price of $10 per share and another trading at a price of $20 per share and think the latter company is worth twice as much. Of course, that is a completely meaningless comparison without also knowing how many shares outstanding there are for each of the two companies, and then calculating their respective market caps. Comparing the share price of RGLS versus a peer is one thing; comparing RGLS market cap versus a peer is a completely different story. Furthermore, via fluctuation both in per-share price and in the number of shares outstanding (via issuance of new shares over time, the repurchase of existing shares), the market cap for a company like RGLS can fluctuate over the course of history. With this page we aim to empower investors researching RGLS by allowing them to research the RGLS market cap history. |
| RGLS Current Stock Quote |
 Free RGLS Email Alerts:
Get Dividend Alerts 
Get SEC Filing Alerts
|
| Video: The Importance of Market Cap | |
|
Video: The Importance of Market Cap
| RGLS Share Performance |
| Market Cap Peers |
| Regulus Therapeutics (RGLS) is categorized under the Healthcare sector; to help you further research historical market cap numbers, below are some other companies in the same sector:
RGNX Market Cap History |
